Overview

Dabigatran Etexilate in Patients With Mechanical Heart Valves

Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
To validate the dosing algorithm for dabigatran etexilate in patients receiving a mechanical heart valve.
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Dabigatran
Warfarin